<p>Performance of model comparing patients with inflammatory bowel disease vs. gastroenterological controls, for sensitivity levels above 90% (in parenthesis, the correctly classified).</p
Comparison of unassisted and model-assisted performance metrics of clinical experts on the validatio...
Model classification efficacy metrics: precision, recall, F1-score and AUC for test sets and the num...
Characteristics of the patients in the present study compared to both models used.</p
<p>Performance of model comparing Crohn’s disease patients to ulcerative colitis patients (in parent...
<p>Performance measures of the models, both discriminatory power (ability to identify patients at in...
<p>Diagnoses of the gastroenterological controls according to their classification in the model IBD ...
<p>Variables and coefficients of the logistic regression model built with directly or indirectly cal...
<p>Values are presented as medians (pg/ml) with the interquartile range. For the number of bowel res...
AIM: To validate the Montreal classification system for Crohn's disease (CD) and ulcerative colitis ...
<p>Comparison of sample characteristics between healthy controls and IBS patients (N = 41,682).</p
<p>CI: confidence interval</p><p>*p <0.001 for pathologic nodal staging score versus other models.</...
AbstractObjectivesTo compare in patients with inflammatory bowel disease the performance of a value ...
Model-based accuracy of screening and diagnostic tests per category compared to the modelled true st...
<p>Comparison of the performance of our models with that of LACE, assuming a 25% intervention rate.<...
(A) Shown are the scatterplots of the sum of gene set variation (GSVA) enrichment scores (ES) using ...
Comparison of unassisted and model-assisted performance metrics of clinical experts on the validatio...
Model classification efficacy metrics: precision, recall, F1-score and AUC for test sets and the num...
Characteristics of the patients in the present study compared to both models used.</p
<p>Performance of model comparing Crohn’s disease patients to ulcerative colitis patients (in parent...
<p>Performance measures of the models, both discriminatory power (ability to identify patients at in...
<p>Diagnoses of the gastroenterological controls according to their classification in the model IBD ...
<p>Variables and coefficients of the logistic regression model built with directly or indirectly cal...
<p>Values are presented as medians (pg/ml) with the interquartile range. For the number of bowel res...
AIM: To validate the Montreal classification system for Crohn's disease (CD) and ulcerative colitis ...
<p>Comparison of sample characteristics between healthy controls and IBS patients (N = 41,682).</p
<p>CI: confidence interval</p><p>*p <0.001 for pathologic nodal staging score versus other models.</...
AbstractObjectivesTo compare in patients with inflammatory bowel disease the performance of a value ...
Model-based accuracy of screening and diagnostic tests per category compared to the modelled true st...
<p>Comparison of the performance of our models with that of LACE, assuming a 25% intervention rate.<...
(A) Shown are the scatterplots of the sum of gene set variation (GSVA) enrichment scores (ES) using ...
Comparison of unassisted and model-assisted performance metrics of clinical experts on the validatio...
Model classification efficacy metrics: precision, recall, F1-score and AUC for test sets and the num...
Characteristics of the patients in the present study compared to both models used.</p